|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
COLES RALLY/REACTION DAY
Trading: HOLD @ $3
Signal Strength: MEDIUM
Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.
Roger Cole devised a method to use rally and reaction days. Cole disregarded inside and outside days to find three rally days in a row or three reactions in a row. This is like three soldiers or three crows in candlestick pattern analysis, except Cole allowed for inside or outside days to intervene. Three soldiers and three crows, while rare, are extremely reliable. So Cole gave us some relief from a strict definition, but traded off increased frequency at the expense of reliability. Cole also used moving average crossovers to augment the two-day (rally, reaction, inside, outside day) results.
Calculation: Coles Reaction Day:
1) Rally Day: High > High yesterday & Low > Low yesterday;
2) Reaction Day: High > High yesterday & Low < Low yesterday
PROFILE: Opthea (OPT.AX)
Stock Exchange: ASX
Ticker Codes: | OPT.AX | ASX:OPT |
Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.
|UOS United Overseas Australia||0.8||9.6||110,847||0||NEUTRAL|
|MNS Milnes Holdings||0.08||7.1||959,142||0||NEUTRAL|
|ALK Alkane Exploration||0.91||6.5||4,762,492||0||NEUTRAL|
|ABC Adelaide Brighton||3.06||6.3||4,642,840||0||NEUTRAL|
|APE Ap Eagers Holdings||9.01||6.1||633,117||0||NEUTRAL|
|CDV Cardinal Resources||0.37||5.7||1,772,012||0||NEUTRAL|
|RFG Retail Food||0.1||5.4||3,641,364||0||NEUTRAL|